INTRODUCTION
Hereditary angioneurotic edema (HANE) is characterized by potentially life-threatening episodes of painless, nonpruritic, nonpitting edema, usually involving the face, upper airway, gastrointestinal tract and extremities. There are two variants of HANE (1, 2) : type I is characterized by low antigenic and functional levels of a normal C 1 inhibitor protein. In type II, there are normal or increased antigenic levels of a dysfunctional mutant C 1 inhibitor protein together with a reduced concentration of the functional protein.
The C 1 inhibitor is a member of the serine protease inhibitors (SERPINS) (3) which shows activity against the Cl r and Cl s subcomponents of the first component of complement (4) (5) (6) (7) (8) . Moreover, it also inhibits kallikrein (9) , activated Hageman factor (factor XIIa) and plasma thromboplastin antecedent (faxtor XIa or PTA) (10) , plasmin (9) , and tissue plasminogen activator (11, 12) .
The Cl inhibitor shows structural and functional homologies with other human SERPINS such as a-I -antitrypsin, antithrombin III, a-Iantichymotrypsin, a-2-antiplasmin, and heparin cofactor 11 (13) (14) (15) (16) . The reactive center of SER-PINS mimics the substrate of the protease. In the Cl inhibitor protein, this reactive center is an Arg-Thr sequence at residues 444-445 (16) . Binding of the protease cleaves the Arg-444 (P-1)-Thr-445 (P-i') peptide bond and releases a small polypeptide molecule from the carboxy-terminal end of the C 1 inhibitor. The sequences and lengths of SERPINS-reactive center are different (14, (16) (17) (18) (19) , and the P-1 site seems to be involved in determining the target protease specificity of individual SERPINS (16) (17) (18) (19) .
The complete nucleotide sequence of the human C 1 inhibitor gene, which contains eight exons, has been recently determined (14, 21) . A significant feature of the intronic sequences is the increased frequency of Alu 1 repeats. Another feature is that among normal individuals a restriction fragment length polymorphism can be observed after digestion of genomic DNA with HgiAI (14) , which is sometimes useful for following the inheritance of normal and mutant alleles in HANE kindreds (22) . In type I HANE the Alu 1 repeats predispose to intragenic breakpoints and unequal crossing-over (23) , which together with partial deletions (24, 25) , nonsense mutations (26) , and other point mutations (13, 27) are responsible for this disease.
In type II HANE, the dysfunctional C 1 inhibitor molecule usually has an amino acid change due to point mutations. Most often, at codon 444 (CGC) in the P-I site of the reactive center, point mutations changes Arg to His or Cys (13, 27) . CG dinucleotides are the major methylated sequences in vertebrates and they are hotspots for mutations by deamination of 5-methylcytosine (22) and other mechanisms (28, 29, 35) . Other point mutations leading to dysfunctional C 1 inhibitor molecules include Ala-434, Ala-436, and Val-432, among others (13, 20, 27, 30) . In addition, a deletion of Lys-251 that results in acquisition of a new N-glycosilation site (31), a nucleotide insertion (32) , and a cluster of mutations within exon 5 (33) has also been described. Our Table 1 .
PCR Amplification of Genomic DNA DNA was extracted from peripheral mononuclear cells of affected and healthy members of the family using standard procedures (34) . The primers for the PCR analysis were designed from the published sequence (21) . We selected intronic Digestion of Amplified Exon 8 with BsiYI Digestion of the purified PCR product (338 bp) with BsiYI gave rise to two fragments with the expected sizes (200 and 138 bp), and we used this analysis to demonstrate the segregation of this mutation in the five affected members of the studied family (Fig. 3 ). The reactive center mutations occur in a CG dinucleotide, which has been demonstrated to be a hotspot for mutations, probably resulting from deamination of 5-methylcytosine to thymidine (22, 35) .
Target protease specificity must be influenced by non-reactive-center residues, as many investigators have reported. Mutations that generate amino acids substitutions in the hinge region near the reactive center and in other regions of the protein also result in a dysfunctional Cl inhibitor molecule (13, 20, (27) (28) (29) (30) (31) (32) (33) . Substitutions of Arg-444 by His, Cys, Leu, and Ser at the reactive center of the Cl inhibitor molecule are the most frequent defects responsible for the dysfunctional protein. Similarly, replacement of Ala434 (P-12) by Glu, Val432 (P-14) by Glu, and Ala436 (P-10) by Thr also causes the dysfunction. This is probably due to conformational changes in the loop near the reactive center. All SERPINS have a P-12 Ala residue that seems to be critical for the conformational change that occurs during successful interactions between SERPINS and serine proteinases, and this codon is conserved among SERPIN genes (13) .
The reactive center of serpins mimics the substrate of the protease. Recognition of this reactive-center peptide bond results in complex formation between the amino acid residue amino-terminal to this bond (the P1 residue) and the active-site of the protease. Proteases inactivated by the Cl inhibitor recognize the Arg444 (P1)-Thr445 (P-') dipeptide.
Here we report the first mutation involving the codon for Thr445, at the P-i' site of the reactive center, which is substituted by a Pro.
This mutation leads to a new restriction site recognized by BsiYI (13, 27) .
